Initiation strategies for renal-replacement therapy in the intensive care unit.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The timing of renal-replacement therapy in critically ill patients who have acute kidney injury but no potentially life-threatening complication directly related to renal failure is a subject of debate. METHODS: In this multicenter randomized trial, we assigned patients with severe acute kidney injury (Kidney Disease: Improving Global Outcomes [KDIGO] classification, stage 3 [stages range from 1 to 3, with higher stages indicating more severe kidney injury]) who required mechanical ventilation, catecholamine infusion, or both and did not have a potentially life-threatening complication directly related to renal failure to either an early or a delayed strategy of renal-replacement therapy. With the early strategy, renal-replacement therapy was started immediately after randomization. With the delayed strategy, renal-replacement therapy was initiated if at least one of the following criteria was met: severe hyperkalemia, metabolic acidosis, pulmonary edema, blood urea nitrogen level higher than 112 mg per deciliter, or oliguria for more than 72 hours after randomization. The primary outcome was overall survival at day 60. RESULTS: A total of 620 patients underwent randomization. The Kaplan-Meier estimates of mortality at day 60 did not differ significantly between the early and delayed strategies; 150 deaths occurred among 311 patients in the early-strategy group (48.5%; 95% confidence interval [CI], 42.6 to 53.8), and 153 deaths occurred among 308 patients in the delayed-strategy group (49.7%, 95% CI, 43.8 to 55.0; P=0.79). A total of 151 patients (49%) in the delayed-strategy group did not receive renal-replacement therapy. The rate of catheter-related bloodstream infections was higher in the early-strategy group than in the delayed-strategy group (10% vs. 5%, P=0.03). Diuresis, a marker of improved kidney function, occurred earlier in the delayed-strategy group (P<0.001). CONCLUSIONS: In a trial involving critically ill patients with severe acute kidney injury, we found no significant difference with regard to mortality between an early and a delayed strategy for the initiation of renal-replacement therapy. A delayed strategy averted the need for renal-replacement therapy in an appreciable number of patients. (Funded by the French Ministry of Health; ClinicalTrials.gov number, NCT01932190.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prior research has suggested benefit [505] or harm [506] for “early” versus “delayed” initiation of RRT.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [506]
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Uchino, S. (2005) · JAMA · doi:10.1001/jama.294.7.813 · Cited by 4,176
Mermel, L. A., Allon, M., Bouza, E., Craven, D. E., Flynn, P., O'Grady, N. P., Raad, I. I., Rijnders, B. J. A., Sherertz, R. J., & Warren, D. K. (2009) · Clinical Infectious Diseases · doi:10.1086/599376 · Cited by 3,638
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Hoste, E. A. J., Bagshaw, S. M., Bellomo, R., Cely, C. M., Colman, R., Cruz, D. N., Edipidis, K., Forni, L. G., Gomersall, C. D., Govil, D., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3934-7 · Cited by 3,061
Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802639 · Cited by 1,759
Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902413 · Cited by 1,473
Mehta, R. L., Cerdá, J., Burdmann, E. A., Tonelli, M., García-García, G., Jha, V., Susantitaphong, P., Rocco, M., Vanholder, R., Sever, M. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60126-x · Cited by 1,154
Daily Hemodialysis and the Outcome of Acute Renal Failure
Schiffl, H., Lang, S. M., & Fischer, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010877 · Cited by 862 · cited 1×
“Congestive heart failure 24 (8) 32 (10)”
(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.32 · Cited by 757
Vinsonneau, C., Camus, C., Combes, A., Costa de Beauregard, M. A., Klouche, K., Boulain, T., Pallot, J.-L., Chiche, J.-D., Taupin, P., Landais, P., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69111-3 · Cited by 685
Cited by
Items 501–600 of 1,000
Current therapeutic strategies for acute kidney injury
Negi, S., Wada, T., Matsumoto, N., Muratsu, J., & Shigematsu, T. (2023) · Renal Replacement Therapy · doi:10.1186/s41100-023-00502-2 · Cited by 8
Sekandarzad, A., Graf, E., Prager, E. P., Luxenburger, H., Staudacher, D. L., Wengenmayer, T., Bettinger, D., & Supady, A. (2024) · Artificial Organs · doi:10.1111/aor.14774 · Cited by 9
Chaudhuri, D., Herritt, B., Heyland, D. K., Gagnon, L.-P., Thavorn, K., Kobewka, D. M., & Kyeremanteng, K. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617698635 · Cited by 9
“Given the lack of quality evidence, there has been a recent attempt to conduct several large RCTs on the topic.(4,15,17) In response to this, our systematic review summarized only the highest quality evidence available in an attempt to provide a more definitive conclusion.”
BackgroundPassos, R. D. H., Ramos, J. G. R., Gobatto, A. L. N., Caldas, J. R., Macedo, E. M., & Batista, P. B. P. (2018) · Critical Care · doi:10.1186/s13054-018-2009-x · Cited by 11
The Japanese Clinical Practice Guideline for acute kidney injury 2016
Doi, K., Nishida, O., Shigematsu, T., Sadahiro, T., Itami, N., Iseki, K., Yuzawa, Y., Okada, H., Koya, D., Kiyomoto, H., et al. (2018) · Renal Replacement Therapy · doi:10.1186/s41100-018-0177-4 · Cited by 10
ACUTE KIDNEY INJURY DURING CRITICAL ILLNESS – A GLOBAL CHALLENGE
Ostermann, M. (2019) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2019-16-2-83-95 · Cited by 11
Renal outcomes of intensive care burn patients in an Asian tertiary centre
Koniman, R., Kaushik, M., Teo, S. H., Tan, C. W., Li, H. H., Foo, M., Tan, B. K., Chong, S. J., & Tan, H. K. (2019) · Burns · doi:10.1016/j.burns.2019.07.038 · Cited by 8
Xia, Z., He, L., Pan, S.-Y., Cheng, R., Zhang, Q.-P., & Liu, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.580144 · Cited by 10
CALL-K score: predicting the need for renal replacement therapy in cardiogenic shock
Ródenas‐Alesina, E., Wang, V. N., Brahmbhatt, D. H., Scolari, F. L., Mihajlovic, V., Fung, N. L., Otsuki, M., Billia, F., Overgaard, C. B., & Luk, A. C. (2022) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuac024 · Cited by 8
Sitbon, A., Darmon, M., Géri, G., Jaubert, P., Lamouche-Wilquin, P., Monet, C., Lefèvre, L., Baron, M., Harlay, M., Bureau, C., et al. (2022) · Annals of Intensive Care · doi:10.1186/s13613-022-01066-w · Cited by 8
“15, and acute pulmonary edema due to fluid overload responsible for severe hypoxemia despite diuretic therapy) [22].”
BackgroundSoum, E., Timsit, J., Ruckly, S., Gruson, D., Canet, E., Klouche, K., Argaud, L., Garrouste-Orgeas, M., Mariat, C., Vincent, F., et al. (2022) · Critical Care · doi:10.1186/s13054-022-04233-4 · Cited by 10
Self-citationZarbock, A., & Kellum, J. A. (2016) · JAMA · doi:10.1001/jama.2016.11338 · Cited by 8
Jia, Y., Jiang, L., Wen, Y., Wang, M., Xi, X., & Du, B. (2017) · Nephrology · doi:10.1111/nep.13076 · Cited by 8
Hamdi, T. (2018) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000425 · Cited by 8
Clapp, J. T., Diraviam, S. P., Lane-Fall, M. B., Szymczak, J. E., Muralidharan, M., Chung, J. J., Gutsche, J. T., Curley, M. A. Q., Berns, J. S., & Fleisher, L. A. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.05.030 · Cited by 9
Shen, B., Xu, J., Lv, W., Jiang, W., Wang, Y., Nie, Y., Luo, Z., Yang, S., Wang, C., Teng, J., et al. (2019) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2019.11.022 · Cited by 8
Interhospital Transfer and Outcomes in Patients with AKI: A Population-Based Cohort Study
Kitchlu, A., Shapiro, J., Slater, J., Brimble, K. S., Dirk, J. S., Jeyakumar, N., Dixon, S. N., Garg, A. X., Harel, Z., Harvey, A. K., et al. (2020) · Kidney360 · doi:10.34067/kid.0003612020 · Cited by 8
Wait and see for acute dialysis: but for how long?
Ostermann, M., & Lumlertgul, N. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00466-9 · Cited by 10
Why ELAIN and AKIKI Should Not Be Compared: Resolving Discordant Studies
Dreyfuss, D., Hajage, D., & Gaudry, S. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.02.370 · Cited by 8
Self-citationMackenzie, J., & Chacko, B. (2017) · Critical Care · doi:10.1186/s13054-017-1868-x · Cited by 8
“[3] 2016 Urea blood > 112 mg/dL (40 mmol/L) Urea blood > 112 mg/dL (40 mmol/L)”
Vanmassenhove, J., Vanholder, R. C., Biesen, W. V., & Lameire, N. H. (2018) · Seminars in Dialysis · doi:10.1111/sdi.12693 · Cited by 8
Timing of initiating renal replacement therapy in acute kidney injury
Barbar, S. D., Jacquier, M., & Maldiney, T. (2025) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.12.004 · Cited by 9
“The French multicenter Artificial Kidney Initiation in Kidney Injury (AKIKI) trial [2] found that early RRT initiation in Kidney Disease: Improving Global Outcomes (KDIGO) stage 3 ICU patients did not confer a survival advantage over delayed initiation, which only began upon the manifestation of…”
InfluentialLee, Y., Seo, J. H., Seong, J., Ahn, S. M., Han, M. G., Lee, J. A., Kim, J. H., Ahn, J. Y., Jeong, S. J., Choi, J. Y., et al. (2024) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e276 · Cited by 7
“In applying an early CKRT strategy for sepsis-associated AKI, there are concerns regarding the unnecessary exposure of patients whose renal dysfunction would recover spontaneously to the risks associated with CKRT. Unnecessary CKRT can lead to adverse events because of extracorporeal circulation, increased healthcare…”
BackgroundResultInfluentialKubo, T., Takeuchi, T., Inoue, N., Cama-Olivares, A., Chandramohan, D., Tolwani, A., Wille, K. M., Fushimi, K., Neyra, J. A., & Wakabayashi, K. (2025) · Scientific Reports · doi:10.1038/s41598-025-85109-9 · Cited by 8
Nuermaimaiti, M., Wang, M., Lou, R., Wang, N., Si, Q., Wang, T., & Jiang, L. (2025) · Scientific Reports · doi:10.1038/s41598-024-84435-8 · Cited by 9
“Consistent with previous research 2,11,23,26 , this study found no correlation between 28 day mortality and the timing of CRRT initiation (Fig.”
Biomarkers in acute kidney injury settings to predict interventions and outcomes: the MARKISIO study
Chaïbi, K., Picod, A., Boubaya, M., Tubiana, S., Jullien, V., Magréault, S., Placier, S., Mallet, J., Louis, G., Martin‐Lefèvre, L., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05439-y · Cited by 9
“A standard delayed RRT initiation strategy, similar to that used in the AKIKI trial [7], was applied during the observational stage.”
Self-citationChanging the terminology from kidney replacement therapy to kidney support therapy
Raina, R., Joshi, H., & Chakraborty, R. (2020) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13584 · Cited by 8
“…vs late (>48 hours postintubation) CVVHF or CVVHDF No association between timing of CKRT initiation and survival rates (hazard ratio: 0.94) Gaudry et al 2016 (AKIKI trials)18 Multicenter, randomized 207 Early (within 6 hours of KDIGO stage 3 AKI diagnosis, n = 311) vs late (72 hours after…”
BackgroundResultInfluentialMarchiset, A., & Jamme, M. (2022) · Frontiers in Nephrology · doi:10.3389/fneph.2022.877529 · Cited by 11
Ohara, C. N., Suarez, M. I. R., Kitawara, K. A. H., Zamoner, W., Balbi, A. L., & Ponce, D. (2022) · Artificial Organs · doi:10.1111/aor.14401 · Cited by 8
Jolly, F., Jacquier, M., Pecqueur, D., Labruyère, M., Vinsonneau, C., Fournel, I., Quenot, J., Mégarbane, B., Lesieur, O., Leloup, M., et al. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.10.005 · Cited by 8
Self-citationPalevsky, P. M. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000116 · Cited by 7
Acute Kidney Injury Receiving Dialysis and Dialysis Care after Hospital Discharge
Babroudi, S., Weiner, D. E., Neyra, J. A., & Drew, D. A. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000383 · Cited by 8
Plasma as endothelial rescue in septic shock: A randomized, phase 2a pilot trial
Clausen, N. E., Meyhoff, C. S., Henriksen, H., Lindhardt, A., Pott, F. C., Lunen, T. B., Gybel‐Brask, M., Lange, T., Johansson, P. I., & Stensballe, J. (2024) · Transfusion · doi:10.1111/trf.17939 · Cited by 8
Renal replacement therapy in ICU: from conservative to restrictive strategy
Chaïbi, K., Dreyfuss, D., & Gaudry, S. (2025) · Critical Care · doi:10.1186/s13054-025-05271-4 · Cited by 7
“In addition to reducing unnecessary treatment, this conservative approach may help protect kidney function [1– 3].”
Self-citationExternal Validation of Persistent Severe Acute Kidney Injury Prediction With Machine Learning Model
Zappalá, S., Alfieri, F., Ancona, A., Dell’Anna, A. M., & KASHANI, K. B. (2025) · Mayo Clinic Proceedings Digital Health · doi:10.1016/j.mcpdig.2025.100200 · Cited by 7
Acute kidney injury: A critical care perspective for orthotopic liver transplantation
MacDonald, A. J., & Karvellas, C. J. (2019) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2019.12.002 · Cited by 7
Renal replacement therapy during extracorporeal membrane oxygenation
Subbarayan, B., Vivek, V., & Kuppuswamy, M. K. (2020) · Indian Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s12055-019-00920-0 · Cited by 7
Kelly, Y. P., Mistry, K., Ahmed, S., Shaykevich, S., Desai, S. P., Lipsitz, S. R., Leaf, D. E., Mandel, E. I., Robinson, E., McMahon, G. M., et al. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02060221 · Cited by 7
Ethgen, O., Zarbock, A., Koyner, J. L., Echeverri, J. E., Harenski, K., Priyanka, P., & Kellum, J. A. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.12.011 · Cited by 8
Cuartero, M., Betbese, A. J., Nunez, K. E., Baldirà, J., & Ordóñez‐Llanos, J. (2019) · Disease Markers · doi:10.1155/2019/8480925 · Cited by 7
“Despite NGAL’s promising results in general ICU population, the AKIKI [34], ELAIN [35], and the most recent IDEAL-ICU [36] trials showed that wbNGAL combined with KDIGO staging did not improve the timing of renal replacement therapies or patient’s prognosis.”
ResultCirrhosis Management in the Intensive Care Unit
Smith, T. N., de Moraes, A. G., & Simonetto, D. A. (2023) · Seminars in Liver Disease · doi:10.1055/a-2015-1290 · Cited by 8
Bagshaw, S. M., & Wald, R. (2019) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00524-0 · Cited by 19
Nakada, T., Oda, S., Abe, R., & Hattori, N. (2019) · Journal of Artificial Organs · doi:10.1007/s10047-019-01113-7 · Cited by 7
The Current State of Renal Replacement Therapy in the Treatment of Sepsis
Kim, T. G., Магомедов, М. А., Николаевич, П. Д., Владимирович, З. М., Marukhov, A. V., & Чубченко, Н. В. (2021) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2021-18-4-80-89 · Cited by 7
Bagshaw, S. M., Hoste, E. A. J., & Wald, R. (2021) · Critical Care · doi:10.1186/s13054-021-03600-x · Cited by 9
“This was addressed by the recent Artificial Kidney Initiation in Kidney Injury-2 (AKIKI-2) trial [6].”
BackgroundMethodInfluentialPopoff, B., Cabon, S., Cuggia, M., Bouzillé, G., & Clavier, T. (2025) · JMIR Medical Informatics · doi:10.2196/63709 · Cited by 6
“While significant research has focused on the optimal timing for initiating CRRT [11,12], much less attention has been given to the question of when and how to discontinue this therapy [13].”
Guo, L., Wu, X., Cui, X., Li, M., Yang, L., Feng, Y., Zhan, Q., & Huang, L. (2024) · Kidney Diseases · doi:10.1159/000539139 · Cited by 6
Implementation and One-Year Evaluation of Proenkephalin A in Critical Care
Märtin, L., Martin, C., Peine, A., Imöhl, M., Kersten, A., Kramann, R., Saritas, T., Marx, N., Dreher, M., Marx, G., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062602 · Cited by 6
Es-Saad, O., Darraz, A., Alkouh, R., Motiaa, Y., & Labib, S. (2025) · Science Progress · doi:10.1177/00368504251338927 · Cited by 9
Chaïbi, K., Dreyfuss, D., & Gaudry, S. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08254-9 · Cited by 6
“Over the past decade, multicenter randomized trials (AKIKI, IDEAL-ICU, STARRT-AKI, AKIKI2) [8– 11] have reframed the clinical context in ICU setting.”
Self-citationChaïbi, K., Akrour, Y., Louis, G., Lefevre, L. M., Pons, B., Moschietto, S., Boulet, E., Hajage, D., Lebbah, S., Quenot, J.-P., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08357-x · Cited by 6
“Three large randomized controlled trials, AKIKI, IDEAL-ICU, and STARRT-AKI, have shown that, in the absence of immediate life-threatening complications, RRT initiation can safely be delayed, allowing 38 to 49% of patients with severe AKI to avoid RRT [5–8].”
Self-citationWang, K., Xiong, H., Zhu, Y., Zhou, Y., & Kang, Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-46063-2 · Cited by 8
“However, several landmark randomized controlled trials (RCTs) published after this period, most notably the AKIKI trial (2016) 36 and the STARRT-AKI trial (2020) 37 , failed to show a survival benefit for an “accelerated” or “early” strategy compared to a “standard” or “delayed” approach.”
Timing of kidney replacement therapy initiation in acute kidney injury
Meraz-Muñoz, A., Bagshaw, S. M., & Wald, R. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000707 · Cited by 6
“DELAYED IN THE INTENSIVE CARE UNIT TRIAL The Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit (IDEAL-ICU) trial was conducted at 29 centers in France to test the hypothesis that an early strategy for initiation of KRT would confer a decrease in 90-day all-cause mortality in critically ill patient…”
BackgroundUromodulin in sepsis and severe pneumonia: a two-sample Mendelian randomization study
Eriksson, M., Lipcsey, M., Ilboudo, Y., Yoshiji, S., Richards, J. B., & Hultström, M. (2024) · Physiological Genomics · doi:10.1152/physiolgenomics.00145.2023 · Cited by 6
Suzuki, G., Nishioka, S., Kobori, T., Masuyama, Y., Yamamoto, S., Serizawa, H., Nakamichi, Y., & Honda, M. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2404237 · Cited by 6
“[4–8], patients who already met the non-emergent initiation (described below) at admission, gastrointestinal bleeding (as the Bun levels would be elevated), RRt required for treatment of drug toxicity or liver failure, patients requiring venoarterial extracorporeal membrane oxygenation (Va-ECMO),…”
BackgroundMethodLau, M. P. X. L., Ling, R. R., Ong, B. J. A., Cho, H. J., Jeong, I. S., Sahoo, T. K., Chua, H., Shekar, K., & Ramanathan, K. R. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2486557 · Cited by 7
“Whilst not specifically on ECMO patients, several RCTs on adults with critical illness have noted no benefit in early initiation of KRT as well, with some even reporting harm such as increased dependence on KRT and catheter related bloodstream infections [50,51].”
Early versus standard renal replacement therapy after left ventricular assist device implantation
Liu, H., Jeng, E. I.-H., Demos, D. S., Vilaro, J. R., Ahmed, M. M., Parker, A. M., Wever‐Pinzon, J., Aranda, J. F., Beaver, T. M., & Arnaoutakis, G. J. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14873 · Cited by 6
“The Artificial Kidney Initiation in Kidney Injury trial enrolled predominantly medical ICU patients with AKI stage III who required mechanical ventilation and/or catecholamine infusion and criteria of early group was RRT within 6 hours.(12) The Early versus Late Initiation of Renal Replacement Therapy in Critically Il…”
MethodOn estimation and cross‐validation of dynamic treatment regimes with competing risks
Morzywołek, P., Steen, J., Biesen, W. V., Decruyenaere, J. M. A., & Vansteelandt, S. (2022) · Statistics in Medicine · doi:10.1002/sim.9568 · Cited by 7
Yadav, M., Tiwari, A. N., Lodha, R., Sankar, J., Khandelwal, P., Hari, P., Sinha, A. P., & Bagga, A. (2022) · The Indian Journal of Pediatrics · doi:10.1007/s12098-022-04214-z · Cited by 7
Wang, X., Wang, H., Du, X., Wang, Z., Li, C., Anderson, C. S., Zhang, J., Hou, X., & Dong, J. (2022) · Trials · doi:10.1186/s13063-022-06617-x · Cited by 6
“However, the optimal timing of CRRT is uncertain: the positive results of the early vs late initiation of renal replacement therapy in critically ill patients with acute kidney injury (the ELAIN) trial [7] were not confirmed in another study, the Artificial Kidney Initiation in Kidney Injury (AKIKI) [8].”
Unsupervised clustering reveals phenotypes of AKI in ICU COVID-19 patients
Sangla, F., Marchi, E., Assouline, B., Terrier, C. L., Sgardello, S. D., Pugin, J., Criton, G., & Legouis, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.980160 · Cited by 7
“Finally, mortality varied between the 3 clusters (18% [3-29], 30% [8-54] and 40% [28-52] respectively, Figure 3e).”
BackgroundChadha, R., Sakai, T., Rajakumar, A., Shingina, A., Yoon, U., Patel, D., Spiro, M. D., Bhangui, P., Sun, L.-Y., Humar, A., et al. (2023) · Transplantation · doi:10.1097/tp.0000000000004803 · Cited by 6
Kal, D. O., Klein, J., Erume, J., Kankya, C., Jubara, A. S., Ikwap, K., Odoch, T., Munyeme, M., Alinaitwe, L., Kitale, E., et al. (2024) · BMC Veterinary Research · doi:10.1186/s12917-024-04154-0 · Cited by 6
“…was performed according to the predominant serovars reported by Sebek et al. (1989) from Sudan and within East African countries, e.g., Uganda [24–27], Kenya [28], Tanzania [29], and Ethiopia [30, 31]. serovar cultures from seven-day-old live Leptospira spp. were used to screen the serum…”
BackgroundNierenersatztherapie im akuten Nierenversagen
Klein, S., & Joannidis, M. (2017) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-017-0290-0 · Cited by 8
Lee, D. H., Lee, B. K., Cho, Y. S., Jung, Y. H., Lee, S. M., Park, J. S., & Jeung, K. W. (2017) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2017.0039 · Cited by 6
“It remains inconclusive whether the early initiation of renal replacement therapy (RRT) in critically ill patients results in reduced mortality (Gaudry et al. , 2016; Zarbock et al. , 2016).”
Gao, Y., Qi, Z., Liu, R., Liu, H., Han, Q., Zhang, X., Huang, R., Li, M., Yang, Z., Zheng, J., et al. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000180 · Cited by 6
CSN COVID-19 Rapid Review Program: Management of Acute Kidney Injury
Clark, E. G., Hiremath, S. S., Soroka, S., Wald, R., Weir, M. A., On behalf of the CSN COVID-19 Rapid Response Team, Antonsen, J. E., Banks, C. A., Clark, D. A., Copland, M. A., et al. (2020) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358120941679 · Cited by 7
Zheng, M., Yin, C., Cao, Y., Zhang, Y., Zhang, K., Zhang, X., Bian, W., & Wang, L. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043385 · Cited by 7
Duyu, M., & Turkozkan, C. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13811 · Cited by 7
“Two randomized controlled trials in critically ill adults with AKI showed conflicting results, while the ELIAN study suggested lower mortality with early CRRT [28], the AKIKI trial showed no difference [29].”
ResultAcute Kidney Injury in ECMO Patients
Ostermann, M., & Lumlertgul, N. (2021) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-030-73231-8_18 · Cited by 8
González, C. A., Pinto, J. L., Orozco, V., Contreras, K., García, P., Rodríguez, P., Trejos, J. A. P., & Echeverri, J. E. (2018) · Cogent Medicine · doi:10.1080/2331205x.2017.1407485 · Cited by 6
“Many studies had evaluated the strategy of early initiation of RRT; recently two clinical trails had demonstrated the history of that inconsistency, both only considering early or delayed initiation based on renal dysfunction characteristics in all the etiologic spectrum of AKI (Gaudry et al., 2016; Zarbock et al., 20…”
BackgroundKlingele, M., & Baerens, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10153379 · Cited by 6
“However, in most studies an early start of dialysis had no beneficial influence on mortality, especially not in patients with sepsis and/or multiple organ failure [4,5].”
BackgroundInitiation of renal replacement therapy in patients with sepsis: more to it than meets the eye
Uhel, F., Sengers, H. P., & van der Poll, T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.12.36 · Cited by 7
“In contrast, in the multicenter AKIKI study including 620 patients from mainly medical ICUs with more severe KDIGO stage-3 AKI, the delayed “wait-andsee” strategy could avoid RRT in 49% of patients and did not show any difference in day-60 mortality (12).”
ResultIncidence and Patient Outcomes in Renal Replacement Therapy After Orthotopic Liver Transplant.
Ayhan, A., Ersoy, Z., Ulaş, A., Zeyneloğlu, P., Pirat, A., & Haberal, M. A. (2017) · Experimental and Clinical Transplantation · doi:10.6002/ect.mesot2016.p126 · Cited by 6
Failing kidneys: renal replacement therapies in the ICU
Patel, P. P., & Egodage, T. (2024) · Trauma Surgery & Acute Care Open · doi:10.1136/tsaco-2024-001381 · Cited by 6
Alactic base excess predicts the use of renal replacement therapy in patients with septic shock
Díaz, J. S. S., Moguel, K. G. P., Gaxiola, F. B., Ruiz, J. M. R., Pérez‐Nieto, O. R., & Sánchez, M. V. C. (2023) · Renal Replacement Therapy · doi:10.1186/s41100-023-00494-z · Cited by 5
“Our study demonstrated that ABE ( ≤ − 5.7 mmol/L) and urea (> 75 mg/dL) are independent risk factors for RRT. Studies on the timing of RRT have included severe metabolic acidosis as one of the absolute indications; in fact, the variables considered were pH < 7.15 and HCO 3 − < 18 mEq/L [28, 29].”
BackgroundInfluentialLiao, J. M., Xiao, X., Lu, D., Wang, M., & Huang, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327914 · Cited by 5
“For example, early CRRT initiation in high-ACAG patients could mitigate acid-base disturbances and inflammatory cascades, as suggested by Gaudry et al. (2016) [30].”
Volume Management with Kidney Replacement Therapy in the Critically Ill Patient
Wang, C. H., Fay, K., Shashaty, M. G. S., & Negoianu, D. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000164 · Cited by 5
The intensity of organ support: Restrictive or aggressive therapy for critically ill patients
Li, H., Li, Y., Fu, Y., Zhang, X., & Zhang, D. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.04.002 · Cited by 5
10 tips on how to use dynamic risk assessment and alerts for AKI
Quickfall, D., La, A. M., & Koyner, J. L. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae325 · Cited by 5
Kal, D. O., Dreyfus, A., Erume, J., Kankya, C., Jubara, A. S., Ikwap, K., Odoch, T., Munyeme, M., Alinaitwe, L., Kitale, E., et al. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012700 · Cited by 5
Jiao, R., Lu, X., Liu, M., Zhu, J., Sun, L., & Liu, N. (2025) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2024.10.034 · Cited by 5
Dialysis Dependence in Standard versus Accelerated Initiation of KRT in AKI
McCoy, I. E., Liu, K. D., Ghamarian, E., Quenot, J., Zarbock, A., Bihorac, A., Khoo, B. Z. E., Gallagher, M., Du, B., Joannidis, M., et al. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000672 · Cited by 6
Zhou, Y., Liu, M., Lin, X., Jiang, J.-H., & Zhuo, H. (2025) · Chinese Journal of Traumatology · doi:10.1016/j.cjtee.2024.12.003 · Cited by 5
“6,29 This study did not include a comparative analysis of patients without hemopur-i fi cation.”
Julien, M., Rafat, C., Raffray, L., Vacher-Coponat, H., Allou, N., Allyn, J., Jabot, J., & Lombardi, Y. (2025) · Annals of Intensive Care · doi:10.1186/s13613-025-01477-5 · Cited by 5
“Nonetheless, these results are at odds with several landmark trials performed in the intensive care settings on patients with septic shock, which found no benefit from early compared with delayed RRT, on patient mortality and other outcomes [24–26].”
InfluentialQuenot, J., Amrouche, I., Lefrant, J., Klouche, K., Jaber, S., du Cheyron, D., Duranteau, J., Maizel, J., Rondeau, É., Javouhey, É., et al. (2021) · Blood Purification · doi:10.1159/000518919 · Cited by 5
Self-citationOutcomes of Continuous Renal Replacement Therapy in a Community Health System
Schaffer, P., Chowdhury, R. B., Jordan, K. M., DeWitt, J., Elliott, J. O., & Schroeder, K. (2021) · Journal of Intensive Care Medicine · doi:10.1177/08850666211052871 · Cited by 5
Early initiation of renal replacement treatment in patients with acute kidney injury
Wang, H., Li, L., Chu, Q., Wang, Y., Li, Z., Zhang, W., Li, L., He, L., & Ai, Y. (2016) · Medicine · doi:10.1097/md.0000000000005434 · Cited by 5
Lee, J. M., Baek, S. D., Kim, T. H., Jeon, H. R., Han, J., & Chang, J. W. (2021) · Shock · doi:10.1097/shk.0000000000001752 · Cited by 5
Insuffisance rénale aiguë chez les patients COVID-19 en soins intensifs
Gabarre, P., Dumas, G., & Zafrani, L. (2021) · Médecine Intensive Réanimation · doi:10.37051/mir-00069 · Cited by 9
“Le délai et les modalités de l’épuration extra-rénale devraient être les mêmes que ceux appli-qués au sepsis [65] .”
Determinants of Major Adverse Kidney Events in Extracorporeal Membrane Oxygenation Survivors
Bobba, A., Costanian, C., Bahous, S. A., & Tohme, F. A. (2022) · Critical Care Explorations · doi:10.1097/cce.0000000000000636 · Cited by 5
For safe and adequate blood purification therapy in severe COVID-19 ‒ what we have learned so far
Katagiri, D. (2022) · Global Health & Medicine · doi:10.35772/ghm.2022.01004 · Cited by 5
Clinical management of postcardiotomy shock in adults
Vela, J. L. P., Jorge, C. L., Álvarez, J. D., & Rivera, J. J. J. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.04.014 · Cited by 10
Shang, Y., Wu, J., Liu, J., Long, Y., Xie, J., Zhang, D., Hu, B., Zong, Y., Liao, X., Shang, X., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.07.001 · Cited by 5
Guo, S., Chen, Y., Huo, Y., Zhao, C., Zhang, K., Zhang, X., Liu, M., & Hu, Z. (2023) · Translational Andrology and Urology · doi:10.21037/tau-23-146 · Cited by 6
“Sepsis-induced cardiomyopathy 12 [8] 4 [5] 8 [11] 0.”
When to discontinue renal replacement therapy. what do we know?
Boyer, N., Perschinka, F., Joannidis, M., & Forni, L. G. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001101 · Cited by 8
Impact of dexamethasone in severe COVID-19-induced acute kidney injury: a multicenter cohort study
Rubin, S., Orieux, A., Prezelin‐Reydit, M., Garric, A., Picard, Y., Mellati, N., Gall, L. L., Dewitte, A., Prével, R., Gruson, D., et al. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01258-6 · Cited by 5
“Since 2017, criteria for RRT initiation have been standardized in the ICUs participating in the study, according to the delayed strategy of the Artificial Kidney Initiation in Kidney Injury (AKIKI) trial [15].”
MethodSelf-citationIndications and timing of renal replacement therapy
Granado, R. C., & Macedo, E. M. (2018) · Gaceta Médica de México · doi:10.24875/gmm.m18000068 · Cited by 5
Cui, J., Tang, D., Chen, Z., & Liu, G. (2018) · BioMed Research International · doi:10.1155/2018/6942829 · Cited by 8
“Although RRT considerably increases the complexity of treatment for these patients, the best time for initiation of RRT remains a subject of debate [27, 28].”
BackgroundThe pressing need for real-time risk assessment of hospital-acquired acute kidney injury
Warnock, D. G. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw282 · Cited by 5
Metadata
- Authors
- Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., de Prost, N., Lautrette, A., Bretagnol, A., Mayaux, J., Nseir, S., Megarbane, B., Thirion, M., Forel, J.-M., Maizel, J., Yonis, H., Markowicz, P., Thiery, G., Tubach, F., Ricard, J.-D., & Dreyfuss, D.
- Affiliations
- Inserm (FR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-07-14
- Volume
- 375
- Issue
- 2
- Pages
- 122-133
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2380810418
- Cited by
- 1,243
- References
- 41
- Citations by year
- 2026: 114 · 2025: 128 · 2024: 115 · 2023: 80 · 2022: 126 · 2021: 127 · 2020: 130 · 2019: 128 · 2018: 124 · 2017: 115 · 2016: 50
- FWCI
- 139.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- acute kidney injury, renal replacement therapy, dialysis initiation timing, critically ill patients, intensive care unit, mortality, catheter-related bloodstream infection, diuresis, mechanical ventilation, catecholamine infusion, oliguria, hyperkalemia, metabolic acidosis, pulmonary edema, blood urea nitrogen, KDIGO staging
- MeSH terms
- Aged, Follow-Up Studies, Humans, Intensive Care Units, Middle Aged, Severity of Illness Index, Urine, Renal Replacement Therapy, Kaplan-Meier Estimate, Acute Kidney Injury, Time-to-Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.